The results of a phase 3 trial suggest cefepime-taniborbactam is a treatment option for patients with complicated UTIs caused by difficult-to-treat, gram-negative bacteria.
MERS-CoV antibody reactivity was identified in 7 of 48 camel-slaughterhouse workers (15%).
Treatment shortened symptoms by a day and also reduced viral loads.
Having tools to identify outbreaks early is crucial for containing outbreaks for both dangerous pathogens.
At least half of US adults hospitalized with uncomplicated community-acquired pneumonia in 2020 received 7 days or more of antibiotics.
Girls (43%) were more likely than boys (35%) to have received one or more HPV vaccine doses.
Sensitivity was 99% for all patients and 100% in the people affected by HIV.
The vaccine campaign targets 610,000 people in South Sudan's Western Equatoria state.
Long COVID was not associated with any one trimester of pregnancy.
During the 6-years analysis, maternal infections rose 222%.
New data from a study in low- and middle-income countries shows a dose of azithromycin before planned vaginal delivery saves more than $32,000 per 100,000 pregnancies.
A team of researchers from Harvard is developing synthetic antibiotics enhanced to overcome resistance mechanisms.
Chlorination wasn't required for the city's water system, and city officials are developing a disinfection plan and considering their next steps.
The woman had bought a duck at a live market, and meat samples were positive for H10N5.
The NIH is investing $515 million more in its long COVID research program.
So far, the cases have been detected in 3 South African provinces and aren't fueling a resurgence in cases.
A population-based study in Shanghai finds COPD patients are nearly 8 times more likely to use antibiotics than the general population.
COVID-19 was associated with a 30% increased subsequent risk of a first cardiovascular event.
The patient is the brother of a boy who recently died from an H5N1 infection.
The authors acknowledge that the findings may have been influenced by confounding factors and bias.
As small clusters continue, the CDC notes that only 1 in 4 eligible people have received both mpox vaccine doses.
Nirsevimab effectiveness was greater than 70% in infants under 9 months.
The CDC says other antibiotics should be considered for prevention among close contacts in areas where ciprofloxacin-resistant cases have been reported.
Gepotidacin showed non-inferiority in one phase 3 trial, and superiority in another, compared with first-line treatments for uncomplicated UTIs.
The latest case, which was fatal, marks the third of 2024.